Zoetis vs Bristol Myers Squibb vs Johnson & Johnson and 1 More Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Zoetis 2.468, Bristol Myers Squibb 12.973, Johnson & Johnson 25.31, Viatris 3.757.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Zoetis, Bristol Myers Squibb, Johnson & Johnson, Viatris.| Metric | Zoetis | Bristol Myers Squibb | Johnson & Johnson | Viatris |
|---|---|---|---|---|
| Market Cap | $30.91B | $120.77B | $630.04B | $20.26B |
| Revenue | $2.47B | $12.97B | $25.31B | $3.76B |
| Cost of Revenue | $673.00M | $3.73B | $8.05B | $2.30B |
| Gross Profit | $1.79B | $9.25B | $17.26B | $1.46B |
| Operating Income | $937.00M | $4.03B | $7.17B | $6.00M |
| Net Income | $691.00M | $3.32B | $5.53B | $-119.00M |
| R&D Expense | $173.00M | $2.96B | $3.65B | $248.00M |
| Earnings Per Share | $1.65 | $1.62 | $2.27 | -$0.1 |
| Gross Margin | 72.7% | 71.3% | 68.2% | 38.8% |
| Operating Margin | 38.0% | 31.0% | 28.3% | 0.2% |
| Net Profit Margin | 28.0% | 25.6% | 21.9% | -3.2% |
| Free Cash Flow | $538.00M | $3.09B | $3.39B | $329.00M |
| Cumulative Free Cash Flow | $18.23B | $168.10B | $383.40B | $22.87B |
| Operating Cash Flow | $655.00M | $3.39B | $4.71B | $382.00M |
| Cash & Equivalents | $1.48B | $8.72B | $20.42B | $886.00M |